NeuroPace Announces Participation at Two Upcoming Healthcare Investor Conferences

Rhea-AI Summary

NeuroPace (Nasdaq: NPCE), a medical device company focused on epilepsy treatment, has announced its participation in two upcoming healthcare investor conferences in September. The company will:

• Host one-on-one meetings with investors at the Lake Street Big8 Best Ideas Growth Conference on September 12th in New York
• Present at the Cantor Global Healthcare Conference from September 17th-19th in New York, featuring a fireside chat with CEO Joel Becker and CFO Rebecca Kuhn on September 18th at 11:30am ET

The fireside chat will be available via live webcast and a replay will be accessible on NeuroPace's Investor website. These conferences provide opportunities for NeuroPace to engage with investors and showcase its innovations in epilepsy treatment.

MOUNTAIN VIEW, Calif., Aug. 27, 2024 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a medical device company focused on transforming the lives of people living with epilepsy, today announced it will participate in the following two healthcare investor conferences in September.

• Lake Street Big8 Best Ideas Growth Conference - NeuroPace management will host one-on-one meetings with investors at the Lake Street Big8 Best Ideas Growth Conference on Thursday, September 12^th in New York.
  
• Cantor Global Healthcare Conference - NeuroPace will present at the Cantor Global Healthcare Conference, which takes place September 17^th-19^th, in New York. Joel Becker, Chief Executive Officer, and Rebecca Kuhn, Chief Financial Officer, will participate in a fireside chat discussion on Wednesday, September 18^th at 11:30am ET, and host one-on-one meetings with investors during the conference. The fireside chat will be accessible via a live webcast here and a replay will be available on the Events section of NeuroPace’s Investor website at https://investors.neuropace.com/news-and-events/events.
  
  

About NeuroPace, Inc.
Based in Mountain View, Calif., NeuroPace is a medical device company focused on transforming the lives of people living with epilepsy by reducing or eliminating the occurrence of debilitating seizures. Its novel and differentiated RNS System is the first and only commercially available, brain-responsive platform that delivers personalized, real-time treatment at the seizure source. This platform can drive a better standard of care for patients living with drug-resistant epilepsy and has the potential to offer a more personalized solution and improved outcomes to the large population of patients suffering from other brain disorders.

Investor Contact:
Jeremy Feffer
Managing Director
LifeSci Advisors
jfeffer@lifesciadvisors.com

FAQ

What investor conferences will NeuroPace (NPCE) attend in September 2024?

NeuroPace (NPCE) will attend two investor conferences in September 2024: the Lake Street Big8 Best Ideas Growth Conference on September 12th and the Cantor Global Healthcare Conference from September 17th-19th, both in New York.

When is NeuroPace's (NPCE) fireside chat at the Cantor Global Healthcare Conference?

NeuroPace's (NPCE) fireside chat at the Cantor Global Healthcare Conference is scheduled for Wednesday, September 18th, 2024, at 11:30am ET.

Who will represent NeuroPace (NPCE) at the Cantor Global Healthcare Conference?

Joel Becker, Chief Executive Officer, and Rebecca Kuhn, Chief Financial Officer, will represent NeuroPace (NPCE) at the Cantor Global Healthcare Conference.

How can investors access NeuroPace's (NPCE) fireside chat at the Cantor conference?

Investors can access NeuroPace's (NPCE) fireside chat via a live webcast, with a replay available on the Events section of NeuroPace's Investor website at https://investors.neuropace.com/news-and-events/events.